Another word to learn - tauopathy
We need to know about this since we as stroke survivors have a higher risk of getting Alzheimers. But ask your doctor what you can do to prevent that higher risk.
http://www-06.all-portland.net/bst/040/0656/0400656.pdf
Tauopathies are neurodegenerative diseases, including AD (Alzheimer's
disease) and FTLD-T (tau-positive frontotemporal lobar degeneration),
with shared pathology presenting as accumulation of detergent-insoluble
hyperphosphorylated tau deposits in the central nervous system. The
currently available treatments for AD address only some of the symptoms,
and do not significantly alter the progression of the disease, namely
the development of protein aggregates and loss of functional neurons.
The development of effective treatments for various tauopathies will
require the identification of common mechanisms of tau neurotoxicity,
and pathways that can be modulated to protect against neurodegeneration.
Model organisms, such as Caenorhabditis elegans, provide methods
for identifying novel genes and pathways that are involved in tau
pathology and may be exploited for treatment of various tauopathies. In
the present paper, we summarize data regarding characterization of MSUT2
(mammalian suppressor of tau pathology 2), a protein identified in a C. elegans
tauopathy model and subsequently shown to modify tau toxicity in
mammalian cell culture via the effects on autophagy pathways. MSUT2
represents a potential drug target for prevention of tau-related
neurodegeneration.
No comments:
Post a Comment